Working… Menu
Trial record 3 of 3 for:    Belinostat chondrosarcoma | United States

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00413075
Recruitment Status : Completed
First Posted : December 19, 2006
Last Update Posted : July 8, 2015
Spectrum Pharmaceuticals, Inc
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2011
Actual Study Completion Date : August 2011